Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
Saved in:
Main Author: | Emergency Medicine International |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Emergency Medicine International |
Online Access: | http://dx.doi.org/10.1155/2024/9795276 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
by: Dechao Zhan, et al.
Published: (2022-01-01) -
Tension Pneumocephalus Related to Radiotherapy for Nasopharyngeal Carcinoma
by: Esther Jimenez-Jimenez, et al.
Published: (2014-01-01) -
Immunotherapy combined with chemotherapy without locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: two case reports and a literature review
by: Yingna Gao, et al.
Published: (2025-01-01) -
Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
by: Kun-Peng Wu, et al.
Published: (2025-12-01) -
Retracted: The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma
by: Emergency Medicine International
Published: (2024-01-01)